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Abstract
Breast papilloma is a term that describes an intraductal papillary configuration of the mammary
epithelium on macroscopic or microscopic examination. It includes solitary intraductal papillomas,
multiple papillomas, papillomatosis, and juvenile papillomatosis (JP).
Recent advances in mammary ductoscopy (MD) have raised new possibilities in the diagnosis and
treatment of breast papillomas. This technique represents an important diagnostic adjunct in
patients with pathological nipple discharge (PND) by allowing direct visualisation and biopsy of
intraductal lesions and guiding duct excision surgery.
Treatment of breast papillomas often entails surgical duct excision for symptomatic relief and
histopathological examination. Recently, more conservative approach has been adapted. MD-
assisted microdochectomy should be considered the procedure of choice for a papilloma-related
single duct discharge. Furthermore, there is increasing evidence that MD has the potential to
reduce the number of duct excision procedures and minimise the extent of surgical resection.
Imaging-guided vacuum-assisted core biopsy can be diagnostic and therapeutic for papillomas seen
on mammography and/or ultrasound.
Patients with multiple papillomas do have an increased risk of developing cancer and should be kept
under annual review with regular mammography (preferably digital mammography) if treated
conservatively. Magnetic resonance (MR) can be also used in surveillance in view of its high
sensitivity. Because the risk is small, long term and affects both breasts, long-term follow-up is more
appropriate than prophylactic mastectomy. Patients who prove to have solitary duct papilloma have
insufficient increase in the risk of subsequent malignancy to justify routine follow-up.
Introduction
Breast papillomas are a variety of lesions in the breast that
are characterized by a papillary configuration on gross or
microscopic examination (or both). Papillomas consist of
a few broad fronds, abundant stroma, and an epithelium
containing both luminal and myoepithelial cells [1].
These include solitary intraductal papillomas, multiple
papillomas, papillomatosis, and juvenile papillomatosis
(JP). Solitary intraductal papillomas are tumours of major
lactiferous ducts, most frequently observed in women 30
to 50 years of age. They commonly cause a serous or sero-
sanguinous discharge. The discharge is bloodstained in
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approximately one half of women with these papillomas
[2]. Pathological nipple discharge (PND) is a relatively
common symptom accounting for approximately 5% of
all women attending symptomatic breast clinics [3]. Pap-
illoma is the commonest pathological finding in women
with PND accounting for 40% to 70% of cases [3,4], fol-
lowed by adenomatous or papillary epithelial prolifera-
tions (14%). However the incidence of malignancy
(invasive or in situ) as a cause of PND varies between 1
and 23% depending upon the series studied [3]. A solitary
papilloma is not thought to be a pre-malignant lesion [5]
and is considered by some to be an aberration rather than
a true disease process [6].
Multiple intraductal papillomas occur in approximately
10% of cases of intraductal papillomas. Compared to sol-
itary intraductal papillomas, multiple intraductal papillo-
mas tend to occur in the younger patients, are less often
associated with nipple discharge, more frequently periph-
eral, and more often bilateral. Essentially, these lesions
appear to be susceptible to the development of carcinoma
[1]. Carter [7] reported that 2 of 6 patients with multiple
papillomata developed cancer, while only 4 of 58 with
solitary papilloma developed cancer. Haagensen et al. [5]
found that 5 of 51 patients with multiple papillomata
developed cancer, which was a marked contrast to those
with a solitary papilloma, where only 4 of 174 developed
cancer. In Haagensen's series of 68 patients with multiple
papillomas, simultaneous or subsequent carcinoma of the
apocrine papillary and cribriform types was observed in
22 patients (32%) [8]. These findings were confirmed by
another study, in which surgically excised specimens from
patients with intraductal papillomas were subjected to
three dimensional reconstruction [9]. All 16 cases of mul-
tiple papillomas in the series were found to originate in
the most peripheral portion of the duct system; the termi-
nal duct lobular unit. Furthermore, malignancy was asso-
ciated with these multiple peripheral papillomas in six
cases (37.5%). In contrast, no cases of carcinoma were
found to be associated with solitary papillomas involving
the large ducts. These findings suggest that peripheral pap-
illomas, on the contrary to solitary central papillomas,
may be highly susceptible to malignant transformation.
Papillomatosis is a term used to describe microscopic foci
of intraductal hyperplasia that have papillary architecture
and are, therefore included by Dupont and Page in the cat-
egory of proliferative lesions without atypia [10]. JP is a
rare condition that affects women between the ages of 10
and 44. Patients typically present with a painless mass
that, on physical examination, is circumscribed, easily
mobile, and most often thought to be a fibroadenoma
[11]. Follow up studies have suggested that JP is associ-
ated with an increased risk of breast cancer in the patient's
female relatives, and the patient herself may be at
increased risk for developing carcinoma, particularly if the
lesion is bilateral and the patient has a family history of
breast cancer [11-14].
Diagnostic methods
Intraductal papillary lesions of the breast continue to be
one of the most difficult diagnostic and therapeutic prob-
lems for the surgeon as they may be histologically benign,
borderline, or malignant. Subsequent surgical treatment
depends largely on the histological appearance of the
lesion.
Physical examination
In patients with PND who do not exhibit palpable
tumours, the localization of intraductal papilloma should
be confirmed by localizing the orifice of the affected duct
on the surface of the nipple and applying pressure with
the fingertip to the circumference of the areola. The secre-
tion of serous or bloody nipple discharge does not distin-
guish intraductal papilloma from cancer [15]. When a
tumour is revealed by delicate palpation it should be char-
acterized in terms of the number of tumours, size, consist-
ency, surface and margin.
Mammography
Simple mammography should be performed in all
patients complaining of bloody or serous PND before
ductography especially if they are aged 35 years or over
[16]. Intraductal papilloma cannot be detected by conven-
tional mammography. If micro-calcification (MCC) is
identified on mammography, then further investigations
in the form of stereotactic core biopsy are required espe-
cially if the MCC is polymorphic, clustered, or linearly dis-
Mammary ductoscopy image showing intraductal papilloma Figure 1
Mammary ductoscopy image showing intraductal papilloma.International Seminars in Surgical Oncology 2006, 3:1 http://www.issoonline.com/content/3/1/1
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tributed. Conventional analogue mammography, as a
screening tool for breast cancer, has a positive predictive
value of only 25%. The diagnostic yield is particularly low
in young women who have dense breasts [17]. This diag-
nostic yeild can be improved by using digital mammoga-
phywhich has been shown to be significantly better than
film mammography among women younger than 50
years compared with those who were at least 50 (P =
0.002). Moreover, digital mammography was more accu-
rate than film mammography among women with heter-
ogeneously dense or extremely dense breasts (P = 0.003)
[18]. Furthermore, computer-aided detection (CAD) can
further improve the sensitivity of digital mammography
in detection MCC [19].
Ductography
Ductography is a safe, simple technique for the visualiza-
tion of the affected duct system in patients with PND.
Intraductal papilloma may be demonstrated by filling
defects within dilated ducts. Solitary papilloma is usually
observed in the collecting ducts, while multiple papillo-
mas are frequently observed in the branching ducts in a
segmental or sub-segmental distribution leading in some
cases to cystic dilatation of the ductal system. Distortion,
narrowing or obstruction of the ducts may indicate the
presence of malignancy. Ductography, however, is a pain-
ful procedure and has considerable limitations in detect-
ing lesions that do not completely obstruct the ductal
lumen, and also in detecting multiple lesions in the same
duct [20]. Therefore the procedure is no longer widely
practised in the management of PND.
Ultrasonography
When the physical examination reveals a palpable abnor-
mality in a localized area of the breast, ultrasonography
may be useful in determining its characteristics; whether it
is a cyst, an intracystic growth or a solid tumour. Modern
high-resolution ultrasound techniques with 3-dimen-
sional views [16] are helpful in visualizing intraductal dis-
orders and are becoming a good complementary
approach if not an alternative to traditional radiology
techniques [16]. Furthermore, there is an increasing evi-
dence that ultrasound-guided percutaneous stereotactic
vacuum core biopsy is a reliable minimally invasive diag-
nostic and therapeutic modality in some clinical scenarios
[21].
MRI
Although magnetic resonance imaging (MRI) seems to be
superior to both mammography and ultrasound for
screening young women who are at high risk of develop-
ing breast cancer, its role in the management of papillo-
mas is currently limited [22-24]. Intraductal papillomas
present with a variable appearance on MRI ranging from
occult to "small luminal mass" papillomas to irregular
rapidly enhancing lesions that cannot be reliably distin-
guished from invasive malignancy [23]. In view of the
The duct is exposed by a skin incision inside the edge of the  nipple-areola complex Figure 3
The duct is exposed by a skin incision inside the edge of the 
nipple-areola complex. The nipple is reflected away from the 
breast tissue in the area covered by the areola. The "blue 
dye" – involved duct is identified and divided as it enters the 
undersurface of the nipple
PND is identified, duct is dilated using appropriate lacrimal  dilators, and MD is gently advanced into the ductal system  until papilloma is identified Figure 2
PND is identified, duct is dilated using appropriate lacrimal 
dilators, and MD is gently advanced into the ductal system 
until papilloma is identified. Blue dye is injected into the 
affected duct.International Seminars in Surgical Oncology 2006, 3:1 http://www.issoonline.com/content/3/1/1
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high sensitivity of MRI, the absence of enhancement typi-
cal of malignancy in women with papillomas can be reas-
suring and supportive of conservative management [24].
However in clinical practice, the high cost, limited exper-
tise and sub-optimal specificity of MRI remain obstacles
to its widespread use [25].
More recently, MR-galactography has been shown to be of
diagnostic value [16].
Cytological examination of nipple discharge
Nipple discharge obtained by squeezing the nipple
should be examined by means of papanicolaou or May-
Giemsa staining in all patients. Cytology smears of the
discharge material provide information about normality,
atypia and malignancy and also about papillary forma-
tion of the exfoliated cells. Tests such as Hemoccult help
to detect occult blood in the secreted fluid. Modern
immunological tests can be performed on cytology smears
where occurrence of high levels of carcinoembryonic anti-
gen could indicate a latent malignancy [15]. Intraductal
papillomas are characterised by the presence of tightly
connected ductal cell clumps. The cells and nuclei are uni-
form in size, and non-mitotic. Erythrocytes are much
more frequently seen in patients with intraductal papillo-
mata. Some papillomas may have cytological appearances
that are indistinguishable from those of ductal carcinoma
in situ [26]. In lesions with associated atypia, however, the
cytomorphologic features may overlap with those of low-
grade carcinoma, and thus tissue biopsy is required for a
definitive diagnosis [27].
Mammary ductoscopy (MD)
Mammary ductoscopy (MD) is a new endoscopic tech-
nique that has been evolving over the last 15 years [20,28-
30]. The initial scopes were of a large calibre with limited
optics and lacked any working channels thus leading to a
poor image quality. Since then, scopes have undergone a
remarkable evolution. The new sub-millimetre fiberoptic
micro-endoscopes measure between 0.7 and 1.2 mm in
external diameter. Recently, Jacobs et al described new
mini-endoscope with 0.55 mm external diameter [31].
Inserted through the ductal opening on the nipple surface,
they allow direct visualization of the mammary ductal
epithelium.
These scopes also provide working channels for insuffla-
tion, irrigation, ductal lavage, and possible therapeutic
intervention [20]. The sharp clear magnified images
viewed on a video monitor combined with the use of
intraductal biopsy devices including micro-brushes and
other biopsy tools allow the retrieval of tissue specimens
under direct visualisation for cyto-pathological analysis
[20,32,33]. Breast ductoscopy can be performed under
local anaesthesia in the office setting with minimal dis-
comfort and no reported complications.
MD offers the advantages of accurate localisation of
pathology, ductal lavage under direct visualization, and
intra-operative guidance especially for lesions deep within
the ductal system [34]. In addition to visualising intraduc-
tal lesions, cytological analysis of endoscopically retrieved
ductal lavage has been recently reported to be more accu-
rate than simple discharge cytology [16,28,35]. In a
cohort of 415 patients with PND, ductoscopy was success-
ful in visualizing an intraductal lesion in 166 patients
(40%). In these cases, ductal lavage following ductoscopy
increased the yield of cytologically interpretable ductal
epithelial cells 100-fold compared to discharge fluid
alone [35]. The authors also reported that of the 11 cases
of DCIS that were initially detected with a combination of
MD and ductal lavage cytology, six were completely nega-
tive on clinical examination and mammography.
Despite these potential benefits of MD in the manage-
ment of papillomas, this new technique is still not widely
used in clinical practice due to the high cost and limited
expertise. This position is likely to change in the near
future.
Treatment
Deciding on the appropriate surgery for intraductal papil-
loma is problematic due to the difficulty in discriminating
between intraductal papilloma and breast cancer. Moreo-
The dissection is carefully carried out caudally around the  involved duct using the bovie cautery Figure 4
The dissection is carefully carried out caudally around the 
involved duct using the bovie cautery. During dissection, 
many dilated major ducts containing fluid can be identified. 
The nipple is gently everted, the subcuticular tissue approxi-
mated with an interrupted layer of 5-0 Vicryl suture. The skin 
is closed with a fine layer of 6-0-monocryl suture, and the 
wound is dressed with sterile strips.International Seminars in Surgical Oncology 2006, 3:1 http://www.issoonline.com/content/3/1/1
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ver, the significance of intraductal papilloma as a pre-can-
cerous lesion is controversial to surgeons. Patients with
multiple papillomas do have an increased risk of develop-
ing breast cancer and should be kept under annual review
with regular digital mammography if treated conserva-
tively. In view of the high sensitivity of MRI, the absence
of enhancement typical of malignancy in women with
multiple papillomas can be reassuring and supportive of
conservative management [24]. Because the risk is small,
long term and affecting both breasts, long-term follow-up
is more appropriate than prophylactic mastectomy.
Patients who prove to have a solitary duct papilloma have
insufficient increase in the risk of subsequent malignancy
to justify routine follow-up.
From a historical perspective the philosophy of manage-
ment of serous or sero-sanguineous nipple discharge
changed radically in the last 50 years. Opinion regarding
the likelihood of it being due to cancer was sharply
divided early in the last century. Judd, [36] in 1917,
reported a 57% incidence of cancer in 100 cases at the
Mayo Clinic. In 1930, Adair reported 108 cases from the
Memorial Hospital, with 47% malignant. In 1931,
Cheatle and Cutler [37] argued strongly from pathological
evidence that benign papillomas could progress to papil-
lary carcinoma. This led to the simple mastectomy being
the standard treatment for blood-stained discharge in
many clinics.
However, in the last 30 years, a more conservative
approach has become accepted, resulting particularly
from the studies of Haagensen in the USA and Atkins and
Wolff [38] in the UK, who all recognized that those
patients whose discharge was due to intraductal papil-
loma were cured by removing the papilloma. Atkins
developed the operation of microdochectomy and Haa-
gensen [8] used a procedure that is intermediate between
the microdochectomy of Atkins and the major duct exci-
sion operation of Urban [39]. If the discharge can be local-
ized to a single duct, microdochectomy gives satisfactory
results in younger patients with a minimal interference
with the breast. In older patients where breast-feeding is
not required, major duct excision may be preferable irre-
spective of whether the discharge is localized to one duct,
both to avoid inconvenience of further discharge from a
different duct and to provide a more comprehensive his-
tology.
MD has recently revolutionised the management of PND
and breast papillomas. The only reliable way to both
establish the diagnosis and control the discharge is ductal
excision, the success of which is dependant on identifying
the correct origin of the discharge. When a specific duct
cannot be identified then blind excision of the retro-areo-
lar ductal system is usually performed. MD offers the
advantages of accurate localisation of pathology, ductal
lavage under direct visualization (figure 1), and intra-
operative guidance especially for lesions deep within the
ductal system [20,30]. Furthermore, MD can detect multi-
ple lesions within the same duct. The technique has the
potential to reduce the number of duct excision proce-
dures and minimise the extent of surgical resection. It is
important to note that in some clinical scenarios, MD-
guided intraductal biopsy can be diagnostic and curative
and the discharge can resolve following the procedure
[16]. This potential therapeutic role of MD-guided intra-
ductal biopsy requires further evaluation and validation.
Simple light trans-illumination through the skin during
MD can be used to guide duct excision. We have recently
described a new technique involving ductoscopy and the
use of a blue dye to perform microdochectomy [40]. The
procedure is performed in an outpatient surgical setting,
under conscious sedation monitored control anaesthesia.
Figures (2, 3, and 4) illustrate the operative technique
used in MD guided microdochectomy. MD can also
potentially reduce the need to perform duct excision in
patients with PND due to benign disease thus resulting in
cost savings.
Dietz et al [4] reported that duct cannulation was achieved
in 105 (88%) of 119 patients with PND and ductoscopy
directed duct excision could be performed in 104 (87%)
of 119 cases. These authors also found that MD was more
accurate than preoperative ductography (90% vs. 76%) in
localising the relevant pathology. The pathological diag-
noses were malignancy in 5 patients, papilloma in 84
cases, and hyperplasia in 16. In 22 patients, ductoscopy
visualised multiple lesions or abnormalities beyond 4 cm.
Such lesions would have been missed by blind duct exci-
sion.
US-guided vacuum-assisted core biopsy of a mass lesion in  the left breast (left) Figure 5
US-guided vacuum-assisted core biopsy of a mass lesion in 
the left breast (left). The lesion has resolved at the end of 
procedure (right).International Seminars in Surgical Oncology 2006, 3:1 http://www.issoonline.com/content/3/1/1
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A proposed algorithm for the management of PND Figure 6
A proposed algorithm for the management of PND. PND: pathological nipple discharge. MCC: Micro calcifications. MD: Mam-
mary Ductoscopy. BCS: Breast conserving surgery
Physical examination
Mammography and/or ultrasound
Discharge cytology
      PND 
      No Yes                Yes             No
Significant abnormality
¾MCC
¾Malignant cytology
¾Indeterminate mass
¾Imaging-guided core
biopsy/Mammotome
¾MRI
¾MD and ductal
lavage +/- biopsy
Evidence of 
malignancy
¾MD guided BCS 
¾Mastectomy
No evidence of 
malignancy
Symptomatic
Reassure
Conservative
treatment
Reassure
Conservative
treatment
MD guided microdochectomy
Symptomatic
No evidence of 
malignancy
MD + ductal lavage +/-
biopsy
No significant abnormality
BenignInternational Seminars in Surgical Oncology 2006, 3:1 http://www.issoonline.com/content/3/1/1
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Nevertheless, MD has recognised limitations. MD exam-
ines 1 – 2 ducts per breast and leaves the remaining 13 –
18 ducts that open at or just below the nipple surface
unexamined. MD is also incapable of reaching the periph-
eral small branches of the ducts due to the scopes' diame-
ter [20,30]. Thus it is unable to visualise the terminal duct-
lobular unit (TDLU) where malignant lesions often origi-
nate. Furthermore complete occlusion of the duct by the
lesion limits the role of MD in the management of PND.
If the papilloma is detectable on mammography and/or
ultrasonography, then imaging-guided vacuum-assisted
biopsy can be both diagnostic and curative (Figure 5).
Dennis et al evaluated the role of imaging-guided vac-
uum-assisted core biopsy as a minimally invasive method
of obtaining a satisfactory diagnosis and eliminating the
bothersome symptoms in patients presenting with nipple
discharge. This study concluded that this technique allows
safe and accurate tissue analysis and a high probability of
terminating the symptomatic nipple discharge [41].
Finally if the discharge is not troublesome and all investi-
gations show no evidence of malignancy, then the dis-
charge can be managed conservatively with no need for
surgical intervention.
Figure 6 shows a new proposed algorithm for the treat-
ment of papillomas.
Future prospects
Current biopsy tools used with MD need further evalua-
tion and validation, as the challenge of verifying endo-
scopic appearances with a histological diagnosis has not
yet been overcome. The future development of reliable
intraductal biopsy tools capable of obtaining tissue sam-
ple under direct visualisation sufficient for histological
diagnosis can enhance further the role of MD in the man-
agement of PND and papillomas. The potential therapeu-
tic role of MD-guided intraductal biopsy [16] requires
further evaluation. MD can also complement other novel
screening modalities such as molecular profiling includ-
ing proteomics in differentiating benign papillomas from
pre-malignant and malignant lesions [42].
Moreover, the addition of radiofrequency [43] to MD as a
curative endoscopic procedure is worthy of investigation.
These potential applications underscore the need to
develop reliable methodology to mark the ducts harbour-
ing pathology.
List of abbreviations
CAD: Computer-aided detection
DCIS: Ductal Carcinoma In-situ
JP: Juvenile Papillomatosis
MCC: Micro-calcifications
MD: Mammary Ductoscopy
MRI: Magnetic Resonance Imaging
PND: Pathological Nipple Discharge
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